Sagent Pharmaceuticals (SGNT) Posts Q1 GAAP Loss of 6c/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/11/2026

1. HUM
2. SPCX
3. ALHC
4. T
5. PEP
6. TMUS
7. SPY
8. CVS
9. UNH
10. ZETA

Go back to Sagent Pharmaceuticals (SGNT) Posts Q1 GAAP Loss of 6c/Share

Sagent Pharmaceuticals Reports First Quarter 2015 Financial Results

May 5, 2015 7:01 AM EDT

SCHAUMBURG, Ill., May 5, 2015 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq: SGNT), a leader of specialty pharmaceutical products with a specific emphasis on the injectable market, today announced financial results for the quarter ended March 31, 2015.

First Quarter 2015 Highlights

Revenue increased 17% to a $82.6 million driven by base business demand and the October 1, 2014 acquisition of Omega Laboratories Limited ("Omega"); Reported gross profit increased 8% to $21.9 million, or 26.5% of net revenue, inclusive of $0.6 million of incremental expense due to the purchase accounting revaluation of Omega inventory; Adjusted Gross Profit1 increased 13% to $23.5 million, or 28.4%... More